Veritas Pharma Issues Incentive Stock Options

December 21, 2017, Vancouver, B.C. – Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP), (“Veritas” or the “Company”) announces the issuance of 2,350,000 stock options at $0.64 to directors, management, and consultants of the Company for a term of twelve...

The Veritas Newsletter

Enter your email to receive news alerts and updates from Veritas Pharma.

You have Successfully Subscribed!